The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism

Hypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF-pathway manipulation is of therapeutic interest, however global, systemic upregulation of HIF may have as yet unknown effects on multiple processes. We utilized a mouse...

Full description

Bibliographic Details
Main Authors: Slingo, Mary, Cole, Mark, Carr, Carolyn, Curtis, Mary K., Dodd, Michael, Giles, Lucia, Heather, Lisa C., Tyler, Damian, Clarke, Kieran, Robbins, Peter A.
Format: Article
Published: American Physiological Society 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/34954/
_version_ 1848794969877250048
author Slingo, Mary
Cole, Mark
Carr, Carolyn
Curtis, Mary K.
Dodd, Michael
Giles, Lucia
Heather, Lisa C.
Tyler, Damian
Clarke, Kieran
Robbins, Peter A.
author_facet Slingo, Mary
Cole, Mark
Carr, Carolyn
Curtis, Mary K.
Dodd, Michael
Giles, Lucia
Heather, Lisa C.
Tyler, Damian
Clarke, Kieran
Robbins, Peter A.
author_sort Slingo, Mary
building Nottingham Research Data Repository
collection Online Access
description Hypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF-pathway manipulation is of therapeutic interest, however global, systemic upregulation of HIF may have as yet unknown effects on multiple processes. We utilized a mouse model of Chuvash polycythemia (CP), a rare genetic disorder which modestly increases expression of HIF target genes in normoxia, to understand what these effects might be within the heart. An integrated in and ex vivo approach was employed. In comparison to wild-type controls, CP mice had evidence (using in vivo MRI) of pulmonary hypertension, right ventricular hypertrophy, and increased left ventricular ejection fraction. Glycolytic flux (measured using 3H glucose) in the isolated, contracting, perfused CP heart was 1.8-fold higher. Net lactate efflux was 1.5-fold higher. Furthermore, in vivo 13C magnetic resonance spectroscopy (MRS) of hyperpolarized 13C1 pyruvate revealed a 2-fold increase in real-time flux through lactate dehydrogenase in the CP hearts, and a 1.6-fold increase through pyruvate dehydrogenase. 31P MRS of perfused CP hearts under increased workload (isoproterenol infusion) demonstrated increased depletion of phosphocreatine relative to ATP. Intriguingly, no changes in cardiac gene expression were detected. In summary, a modest systemic dysregulation of the HIF pathway resulted in clear alterations in cardiac metabolism and energetics. However, in contrast to studies generating high HIF levels within the heart, the CP mice showed neither the predicted changes in gene expression nor any degree of LV impairment. We conclude that the effects of manipulating HIF on the heart are dose-dependent. New and noteworthy This is the first integrative metabolic and functional study of the effects of modest HIF manipulation within the heart. Of particular note, the combination (and correlation) of perfused heart metabolic flux measurements with the new technique of real-time in vivo MR spectroscopy using hyperpolarized pyruvate is a novel development.
first_indexed 2025-11-14T19:24:39Z
format Article
id nottingham-34954
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:24:39Z
publishDate 2016
publisher American Physiological Society
recordtype eprints
repository_type Digital Repository
spelling nottingham-349542020-05-04T18:01:23Z https://eprints.nottingham.ac.uk/34954/ The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism Slingo, Mary Cole, Mark Carr, Carolyn Curtis, Mary K. Dodd, Michael Giles, Lucia Heather, Lisa C. Tyler, Damian Clarke, Kieran Robbins, Peter A. Hypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF-pathway manipulation is of therapeutic interest, however global, systemic upregulation of HIF may have as yet unknown effects on multiple processes. We utilized a mouse model of Chuvash polycythemia (CP), a rare genetic disorder which modestly increases expression of HIF target genes in normoxia, to understand what these effects might be within the heart. An integrated in and ex vivo approach was employed. In comparison to wild-type controls, CP mice had evidence (using in vivo MRI) of pulmonary hypertension, right ventricular hypertrophy, and increased left ventricular ejection fraction. Glycolytic flux (measured using 3H glucose) in the isolated, contracting, perfused CP heart was 1.8-fold higher. Net lactate efflux was 1.5-fold higher. Furthermore, in vivo 13C magnetic resonance spectroscopy (MRS) of hyperpolarized 13C1 pyruvate revealed a 2-fold increase in real-time flux through lactate dehydrogenase in the CP hearts, and a 1.6-fold increase through pyruvate dehydrogenase. 31P MRS of perfused CP hearts under increased workload (isoproterenol infusion) demonstrated increased depletion of phosphocreatine relative to ATP. Intriguingly, no changes in cardiac gene expression were detected. In summary, a modest systemic dysregulation of the HIF pathway resulted in clear alterations in cardiac metabolism and energetics. However, in contrast to studies generating high HIF levels within the heart, the CP mice showed neither the predicted changes in gene expression nor any degree of LV impairment. We conclude that the effects of manipulating HIF on the heart are dose-dependent. New and noteworthy This is the first integrative metabolic and functional study of the effects of modest HIF manipulation within the heart. Of particular note, the combination (and correlation) of perfused heart metabolic flux measurements with the new technique of real-time in vivo MR spectroscopy using hyperpolarized pyruvate is a novel development. American Physiological Society 2016-07-15 Article PeerReviewed Slingo, Mary, Cole, Mark, Carr, Carolyn, Curtis, Mary K., Dodd, Michael, Giles, Lucia, Heather, Lisa C., Tyler, Damian, Clarke, Kieran and Robbins, Peter A. (2016) The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism. American Journal of Physiology – Heart and Circulatory Physiology . ISSN 1522-1539 Hypoxia-inducible factor cardiac metabolism MRI hyperpolarized pyruvate Chuvash polycythemia http://ajpheart.physiology.org/content/early/2016/07/12/ajpheart.00912.2015 doi:10.1152/ajpheart.00912.2015 doi:10.1152/ajpheart.00912.2015
spellingShingle Hypoxia-inducible factor
cardiac metabolism
MRI
hyperpolarized pyruvate
Chuvash polycythemia
Slingo, Mary
Cole, Mark
Carr, Carolyn
Curtis, Mary K.
Dodd, Michael
Giles, Lucia
Heather, Lisa C.
Tyler, Damian
Clarke, Kieran
Robbins, Peter A.
The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
title The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
title_full The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
title_fullStr The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
title_full_unstemmed The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
title_short The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
title_sort von hippel-lindau chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
topic Hypoxia-inducible factor
cardiac metabolism
MRI
hyperpolarized pyruvate
Chuvash polycythemia
url https://eprints.nottingham.ac.uk/34954/
https://eprints.nottingham.ac.uk/34954/
https://eprints.nottingham.ac.uk/34954/